~~<i id='0A8A7334CF'><strike id='0A8A7334CF'><tt id='0A8A7334CF'><pre id='0A8A7334CF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

fashion

author：Wikipedia 2025-09-30 23:33:00 - browse：47

Michel Pairet -- health business coverage from STAT — Michel Pairet Courtesy Boehringer Ingelheim

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.

There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.

In other words, there was a whole lot for the company to discuss as it works to promote its breadth and build partnerships with academic researchers and other companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： New weight loss drugs work. But how can they best be used?

focus

hotspot

knowledge

hotspot

knowledge

4:33NinemembersofCongressandotherswaittoenterMarjoryStonemanDouglasHighSchool,Friday,Aug.4,2023,inPa

WSS

3 medical device trends to watch in 2024

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Pharma needs to include young adults in clinical research

Feng Zhang, Grail founder join forces on new gene editing startup

Scientists find bacteria from stomach of ancient iceman

focus

fashion

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

New weight loss drugs work. But how can they best be used?

Walensky prepares to leave CDC — and Congress — behind

Why psychiatrists like me stop taking insurance

Hepatitis C has a cure — but many Americans still lack access to it

UCB departs biotech trade group BIO

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Ahead of JPM, here's who's profiting most in health care

Alkermes shareholders re

The biotech scorecard for Q1: 17 stock

hotspot

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

'Cuddling' is just what the doctor ordered for a 200

UCB departs biotech trade group BIO

Special counsel alerts court to Trump’s social media post

Federal weight loss drug coverage is 30 years out of date

J&J to buy cancer drug developer Ambrx Biopharma

hotspot

knowledge

hotspot

knowledge